Regulation 6 Amendment of regulation 29 in relation to England, Scotland and Wales (procedures for active implantable medical devices for clinical investigations)
After regulation 29(1)f1, insert—
“(1A)A manufacturer or their UK responsible person may request a meeting with the Secretary of State in advance of giving notice in writing to the Secretary of State pursuant to paragraph (1) in order to—
(a)obtain advice on regulatory requirements relating to an intended clinical investigation; or
(b)obtain a statistical review in relation to an intended clinical investigation.”.
Annotations
Footnotes
- f1
-
Relevant amending instruments are S.I. 2013/2327 and 2019/791.